He is an enthusiast of everything to do with the graphic medium, whether it's Western comics and their adaptations or manga ...

Abbott's deal shakes up cancer diagnostics, new research confirms pandemic fatigue's impact on public compliance, and more in today’s Pharma Pulse.

The New York firm Odyssey is now running the state’s lucrative voucher scheme with a little help from the governor’s friends.

An interim meeting notice just went out for the second week of December, showing the high-profile committee will meet Dec. 10 ...

Exact Sciences, which bought Bay Area cancer testing pioneer Genomic Health in 2019, is projected to generate more than $3 ...

Even with the increasing challenges of accessing public records, Leatherbury and Pillifant were stumped by the governor’s ...

Abbott Laboratories $21 billion deal to acquire cancer test maker Exact Sciences could bolster the company’s diagnostic ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and ...

Abbott announced today that it agreed to acquire diagnostics maker Exact Sciences for approximately $21 billion.

Even with the increasing challenges of accessing public records, Leatherbury and Pillifant were stumped by the governor’s decision to release thousands of pages only to black them out fully.

The U.S. Department of Energy says it's loaning $1 billion to help finance the restart of the nuclear power plant on Pennsylvania’s Three Mile Island to supply power to data centers for tech ...